CODX vs WY · rev $3.9M vs P/E 43, rev $7.12B
Co-Diagnostics, Inc. Common Stock (CODX) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported WY revenue for 2024-12-31 was $7.12B. Net income was $396.0M. Revenue was down 7.2% from 2023-12-31 to 2024-12-31. WY currently screens at market cap $17.54B and trailing P/E 43.4.
CODX currently screens at market cap $31.4M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the CODX and WY stock pages for the full models.
Not investment advice.